This spring, the University of Tennessee Research Foundation was honored to recognize UT innovators from across the state at UTRF’s annual Innovation Awards. For the first time in two years, UTRF staff and valued partners gathered in Knoxville and Memphis to celebrate the innovation coming from the university. At the events, hosted at UT Knoxville (read more)
UTRF News
Employee Spotlight: Shelby Miller
The University of Tennessee Research Foundation team has grown once again! UTRF is proud to welcome Shelby Miller as the Business Incubator Coordinator at the UTRF Business Incubator. Only a month into her role, Miller is excited about new challenges and learning opportunities. Miller is a Knoxville native and May 2021 graduate of East (read more)
UTRF Licensee Veru, Inc. Announces Positive Results of COVID-19 Therapy’s Phase 3 Clinical Study, Seeking Emergency Use Authorization from FDA
UT Research Foundation licensee Veru, Inc. announced on April 11, 2022, that their Phase 3 clinical trial of sabizabulin as an oral therapy for hospitalized severe COVID-19 patients at high risk for Acute Respiratory Distress Syndrome (ARDS) and death showed the drug to be safe and effective. The trial was halted early due to the (read more)